Literature DB >> 15590714

In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.

Francine Mory1, Sébastien Fougnot, Christian Rabaud, Hélène Schuhmacher, Alain Lozniewski.   

Abstract

OBJECTIVES: To evaluate the antibiotic susceptibilities of Propionibacterium acnes isolates from central nervous system (CNS) infections to agents used in current treatment regimens.
METHODS: MICs of 16 reference antibiotics were determined by an agar dilution method for 24 consecutive strains of P. acnes isolated from individual patients with intracranial empyema or brain abscess. Bactericidal activities of antibiotics against P. acnes PAN14 were studied at 0.25-2 x MIC using a time-kill method.
RESULTS: All of the isolates were resistant to fosfomycin, intermediate or resistant to metronidazole and susceptible to all the other antibiotics tested, except for nine strains, which were intermediate to ofloxacin. Among antibiotics tested alone in time-kill experiments, vancomycin was the most effective drug and exhibited bactericidal activity after 24 h at 1x and 2 x MIC, whereas cefotaxime and ciprofloxacin were bactericidal after 48 h at 2 x MIC. No significant bactericidal activity could be demonstrated with the other antibiotics tested alone. The addition of cefotaxime to vancomycin resulted in bactericidal activity at lower concentrations (0.5 x MIC), whereas synergy was observed between quinupristin/dalfopristin and cefotaxime at 2 x MIC. In contrast, antagonism was observed between cefotaxime and linezolid, and ciprofloxacin and clindamycin.
CONCLUSION: Our data suggest that P. acnes isolates causing CNS infections remain highly susceptible to most antibiotics used for the treatment of such infections. Moreover, we showed that cefotaxime, vancomycin and ciprofloxacin possess good bactericidal activities against P. acnes, and that these activities may be enhanced when vancomycin is combined with cefotaxime or when cefotaxime is combined with quinupristin/dalfopristin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15590714     DOI: 10.1093/jac/dkh521

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Mechanism-independent method for predicting response to multidrug combinations in bacteria.

Authors:  Kevin Wood; Satoshi Nishida; Eduardo D Sontag; Philippe Cluzel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-05       Impact factor: 11.205

2.  Acute Hemiparesis in a Healthy Elderly Woman: Where and What Is the Lesion?

Authors:  Ji Hoon Lee; Sung Hyuk Heo; Jin San Lee; Dae-Il Chang; Ki-Ho Park; Ji-Youn Sung; Il Ki Hong; Myeong Hee Kim; Bong Jin Park; Woo Suk Choi
Journal:  Front Neurol       Date:  2017-03-21       Impact factor: 4.003

3.  Genotypic and antimicrobial characterisation of Propionibacterium acnes isolates from surgically excised lumbar disc herniations.

Authors:  Jess Rollason; Andrew McDowell; Hanne B Albert; Emma Barnard; Tony Worthington; Anthony C Hilton; Ann Vernallis; Sheila Patrick; Tom Elliott; Peter Lambert
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

4.  Quantification of the antibody response to Propionibacterium acnes in a patient with prosthetic valve endocarditis: - a case report.

Authors:  T Herren; M A Middendorp; R Zbinden
Journal:  BMC Infect Dis       Date:  2016-04-29       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.